Sheffield Institute for Translational Neuroscience
SITraN is an essential development in the fight against motor neurone disease, other common neurodegenerative disorders, stroke and neuroinflammatory conditions.
The Duchess of Gloucester explores pioneering Parkinson's research at SITraN
Parkinson’s UK Patron, Her Royal Highness The Duchess of Gloucester, met neuroscientists from the University of Sheffield who are tackling the root causes of the progressive condition
New research institute to accelerate the search for a cure for MND
The new UK Motor Neuron Disease Research Institute, or UK MND RI, aims to discover new treatments that could ultimately mean MND becomes a curable condition.
University of Sheffield spinout company Crucible Therapeutics raises £5 million to advance pioneering treatments for neurological diseases
University of Sheffield spinout company, Crucible Therapeutics, a biotechnology company developing novel therapies to treat the most common genetic form of MND and frontotemporal dementia (FTD), has secured £5 million from Northern Gritstone.